stemcell
The Niche

The Niche

Knoepfler lab stem cell blog

  • Home
  • Contact
  • About Us
  • Trial search
  • Treatments
  • Report a clinic
  • RMAT List (37)
  • TED talk
  • Nature
  • Privacy
  • Stem Cell Book
  • Dragon book
  • 2019 Meetings
  • 2020 Meetings
  • Stem cells in your language

RTI Surgical

FDA stem cells

FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces

February 11, 2016 Paul Knoepfler 16

The FDA in the past year or so has issued draft guidances on regulation of stem cells that would, if finalized, make it crystal clear that what many American stem cell clinics are selling are unapproved drugs. That would be […]

Subscribe to this Blog

Join 24,195 other subscribers

Paul KnoepflerFollow

Prof @UCDAVIS Stem cells & Kids Brain Cancer Epigenomics #CRISPR Science policy/ethics. #scicomm TED https://t.co/4XhF0V5XiZ New book on making dragons🐲https://t.co/q9ezUzZdtx

Paul Knoepfler
pknoepflerPaul Knoepfler@pknoepfler·
7h

Wow, Liveyon has stopped sales of unproven umbilical cord cells after FDA warning letter
@lauriemcginley2
https://washingtonpost.com/health/2019/12/13/california-stem-cell-company-halts-sales-after-fda-warning/ Here's my take on that warning letter & other recent FDA steps https://ipscell.com/2019/12/fda-spike-clinic-supplier-liveyon-warning-letter-notice-on-exosome-harms/ I bet @BadBatchWondery podcast also played a role #stemcells

Reply on Twitter 1205609226476777474Retweet on Twitter 12056092264767774744Like on Twitter 12056092264767774745Twitter 1205609226476777474
pknoepflerPaul Knoepfler@pknoepfler·
7h

Bizarro cartoons often have me thinking of sketchy stem cell clinics, when they really having nothing to do with that. #stemcells Have Friday #TGIF

2
Reply on Twitter 1205598971860680704Retweet on Twitter 1205598971860680704Like on Twitter 12055989718606807044Twitter 1205598971860680704
james_jamstewJames Stewart@james_jamstew·
13 Dec

FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms https://ipscell.com/2019/12/fda-spike-clinic-supplier-liveyon-warning-letter-notice-on-exosome-harms/ via @pknoepfler

Reply on Twitter 1205280468796526592Retweet on Twitter 12052804687965265922Like on Twitter 12052804687965265923Twitter 1205280468796526592
Load More...
  • RSS - Posts
  • RSS - Comments

Recent Comments

  • Paul Knoepfler on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms
  • Bill Jones on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms
  • Miss Matadora on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms
  • Miss Matadora on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms
  • Matthew Wilgo on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms

Copyright © 2019 | Knoepfler Lab Stem Cell Blog, UC Davis, 1 Shields Ave, Davis, CA 95616. Designwork by Tradesouthwest Top